TY - JOUR
T1 - Quorum sensing inhibitors
T2 - a patent overview.
AU - Pan, Jiachuan
AU - Ren, Dacheng
N1 - Funding Information:
Dacheng Ren’s previous work on brominated furanones was supported by Electric Power Research Institute, Inc., DuPont E. I. de Nemours & Company, U.S. Environmental Protection Agency and Syracuse Center of Excellence. The authors received no payment for preparation of this manuscript.
Copyright:
This record is sourced from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
PY - 2009/11
Y1 - 2009/11
N2 - BACKGROUND: Quorum sensing (QS) is a microbial cell-cell signaling system that correlates gene expression with cell population density. It plays important roles in intra-species communications and is also involved in inter-species and microbe-host interactions. Because QS controls a wide spectrum of phenotypes including virulence and biofilm formation, inhibition of QS may provide alternative therapeutic methods for treating microbial infections. OBJECTIVE: To provide an overview of QS inhibitors and their applications. METHODS: Search of databases for patents on QS inhibition submitted between 1999 and 2008. RESULTS/CONCLUSIONS: The reported QS inhibitors include both natural and synthetic agents and can be mainly categorized in three classes: nonpeptide small molecules, peptides and proteins. These inhibitors interrupt QS by repressing signal generation, blocking signal receptors or disrupting QS signals, and provide an alternative approach to controlling microbial pathogenesis.
AB - BACKGROUND: Quorum sensing (QS) is a microbial cell-cell signaling system that correlates gene expression with cell population density. It plays important roles in intra-species communications and is also involved in inter-species and microbe-host interactions. Because QS controls a wide spectrum of phenotypes including virulence and biofilm formation, inhibition of QS may provide alternative therapeutic methods for treating microbial infections. OBJECTIVE: To provide an overview of QS inhibitors and their applications. METHODS: Search of databases for patents on QS inhibition submitted between 1999 and 2008. RESULTS/CONCLUSIONS: The reported QS inhibitors include both natural and synthetic agents and can be mainly categorized in three classes: nonpeptide small molecules, peptides and proteins. These inhibitors interrupt QS by repressing signal generation, blocking signal receptors or disrupting QS signals, and provide an alternative approach to controlling microbial pathogenesis.
UR - http://www.scopus.com/inward/record.url?scp=74949122832&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=74949122832&partnerID=8YFLogxK
U2 - 10.1517/13543770903222293
DO - 10.1517/13543770903222293
M3 - Review article
C2 - 19732032
AN - SCOPUS:74949122832
SN - 1354-3776
VL - 19
SP - 1581
EP - 1601
JO - Expert opinion on therapeutic patents
JF - Expert opinion on therapeutic patents
IS - 11
ER -